Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Pharmacists play a crucial role in health literacy and patient care.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

EGCG in green tea benefits skin, hair, cancer treatment, weight loss, diabetes, heart, and brain health.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Vitamin C was found to effectively treat prickly heat in children.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Facebook groups help patients using scalp cooling therapy by offering support, advice, and product recommendations.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Cancer survivors need better skin care to improve their quality of life.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Some drugs used to treat inflammation may cause hair loss.